Global Intragastric Balloon Market

Posted by NISHA SHAHA on February 2nd, 2022

Global Intragastric Balloon Market accounted for US$ 14.2 million in 2020 and is estimated to be US$ 42.24 million by 2030 and is anticipated to register a CAGR of 11.5%. An intragastric balloon is a type of weight-loss procedure. A saline-filled or gas-filled silicone balloon is put in the stomach during this procedure, which aids weight loss by restricting the amount of food consumed. Since 1985, intragastric balloons have been used to treat obesity and to help people lose weight. For optimal results and the elimination of associated issues, many modifications and technological advancements have been made. Since 1985, various intragastric balloons have been authorised for sale in Europe and South America. However, due to a variety of adverse effects and problems, the US FDA did not approve any additional devices until 2015.

The report \" Global Intragastric Balloon Market, By Type (Single Balloon, Dual Balloon, and Triple Balloon), By Application (Hosptials, Ambulatory Surgical Centres, and Clinics), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030’’

Key Highlights:

• Allurion Technologies announced its arrival into Asia in July 2020, with the launch of the Elipse Program in Hong Kong, Malaysia, and Singapore, allowing non-invasive weight loss therapies to be available in the region.
• Allurion Technologies Inc. raised roughly USD 34 million in January 2020 to help fund the launch of its swallowable weight-loss balloon. The funds will be used to expand abroad and launch the company\'s groundbreaking weight-loss programme in the United States.

Analyst View:

Single intragastric balloons are expected to rise in popularity in the future, due to expanding awareness, rising demand for minimally invasive operations, the availability of numerous goods on the market, and scientific demonstrations of their safety and efficacy. For instance,the Orbera intragastric balloon, a form of single fluid-filled intragastric balloon, is safe and effective for lowering obesity-related comorbidities in a real-world population and weight reduction population, according to a National Institute of Health (NIH) paper published in 2018.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Intragastric Balloon Market, By Type (Single Balloon, Dual Balloon, and Triple Balloon), By Application (Hosptials, Ambulatory Surgical Centres, and Clinics), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Intragastric-Balloon-Market-By-3306